| Scientific Name |
Ritlecitinb
|
|---|---|
| Brand Name |
Litfulo
|
| Risk |
Thrombotic events including pulmonary embolism , Potential risk of Infections (including herpes zoster and serious and opportunistic infections) , Potential risk of malignancy , Potential risk of Major Adverse Cardiovascular Events , Embryo-foetal toxicity following exposure in utero
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|